EVERION
LIVE

Serial Number

79210015

Owner

BIOFOURMIS AG

Filing Date

Mar 9, 2017

Add to watchlist:

No watchlists yet
View on USPTO

EVERION Trademark

Serial Number: 79210015 • Registration: 5790099

EVERION is a trademark filed by BIOFOURMIS AG on March 9, 2017. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 38 (Telecommunications), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

BIOFOURMIS AG (2 trademarks)

c/o Biovotion AG,

Entity Type: 99

Biovotion AG (2 trademarks)

Kreuzstrasse 2

Entity Type: 25

BIOSIGNS PTE LTD

2 Venture Drive,

Entity Type: 99

Trademark Details

Filing Date

March 9, 2017

Registration Date

July 2, 2019

Published for Opposition

April 16, 2019

Cancellation Date

January 16, 2026

Goods & Services

Business management and business strategy consulting; cost price analysis; commercial administration of the licensing of the goods and services of others; compilation, collection, analysis and systematization of data in computer databases, namely, business data compilation and database management in the field of medical health, physiological health, and bio-chemical health; data processing services of data in computer databases in the field of healthcare; business strategy consultancy services relating to the data processing in the field of medical health, physiological health, and bio-chemical health; computer file management, namely, management and compilation of computerized databases in the field of medical health, physiological health, and bio-chemical health; computer file management, namely, management and compilation of computerized databases; computerized database management in the field of medical health, physiological health, and bio-chemical health; computer file management, namely, management and compilation of computerized databases; data processing services for others; computerized data processing services

Scientific and technological services as well as research and design relating thereto, namely, blood analysis services in the nature of the monitoring, tracking, collection and assessment of blood chemistry, glucose levels and electrolyte levels, blood properties, blood perfusion index, pulse rate, blood coagulation, blood pressure, activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, information; industrial research and analysis services, namely, industrial research, scientific research, conducting engineering surveys, in the fields of medical and nonmedical technology to monitor, track and report blood chemistry, glucose levels and electrolyte levels, blood properties, blood perfusion index, pulse rate, blood coagulation, blood pressure, activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, information; technical project study, namely, studies in the field of scientific research; development of experimental and clinical testing strategies, namely, testing strategies, testing specifications and procedures for scientific research and clinical trials of medical products and medical technology; research and development services related to new products for others in the field of measuring apparatus, devices and instruments; design and development of computer software; writing of computer programs for data processing; technical advice in the field of science relating to in vivo physiological monitoring; development and programming of data processing computer programs; development of data processing systems, namely, computer programs; Computer software development and computer programming development for others, namely, development and programming of data processing programs; development of data processing systems, namely, data processing programs for third parties

Medical measuring apparatus, devices and instruments for monitoring and tracking of blood chemistry, glucose levels and electrolyte levels, and providing alerts to abnormal levels and significant changes in levels; Non-invasive medical devices for monitoring blood properties, and providing alerts to abnormal levels and changes in levels; Medical devices, namely, hemoglobin and oxygen saturation monitoring and analysis apparatus, and providing alerts to abnormal levels and changes in levels; Medical apparatus for monitoring blood perfusion index; pulse rate monitors; medical devices for monitoring, measuring, and analyzing blood coagulation, blood pressure and other blood properties, and providing alerts of abnormal levels and rates and changes in levels and rates; Medical measuring apparatus, devices and instruments for monitoring and tracking of activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts of abnormal levels and rates and changes in levels and rates; Medical measuring apparatus, devices and instruments for monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure; Medical measuring apparatus, devices and instruments, namely, wearable digital electronic devices for monitoring and tracking of blood chemistry, glucose levels and electrolyte levels, and providing alerts of abnormal levels and rates and changes in levels in rates; Medical measuring apparatus, devices and instruments, namely, wearable digital electronic devices for monitoring and tracking of activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts of abnormal levels and rates and changes in levels and rates; Medical measuring apparatus, devices and instruments, namely, wearable digital electronic devices for monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure

Non-medical measuring apparatus, devices and instruments, namely, wearable activity trackers, computers, computer peripherals, wearable computer and wearable computer peripherals primarily for measuring, monitoring and tracking of activity, energy expenditure and steps, and also including measuring, monitoring and tracking of physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts to abnormal levels and rates and changes in levels and rates; Measuring apparatus, devices and instruments, namely, wearable activity trackers, computers, computer peripherals, wearable computers, and wearable computer peripherals for measuring, monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure; Downloadable computer programs for measuring, monitoring and tracking of blood chemistry, glucose levels and electrolyte levels, and providing alerts to abnormal levels and changes in levels; Downloadable computer programs for measuring, monitoring and tracking of activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts to abnormal levels and rates and changes in levels and rates; Downloadable computer programs for measuring, monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure; Computer software for measuring, monitoring and tracking of blood chemistry, glucose levels and electrolyte levels, and providing alerts to abnormal levels and changes in levels; computer software for measuring, monitoring and tracking of activity, energy expenditure and steps, and physiological and metabolic processes and vital signs in the nature of heart rate, heart rate variability, blood pulse wave characteristics, respiration rate, blood oxygen saturation, blood perfusion, pulse, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity, and providing alerts to abnormal levels and rates and changes in levels and rates; computer software for measuring, monitoring and tracking of barometric pressure and providing alerts to changes in barometric pressure and providing alerts to changes in barometric pressure; Computer software, namely, data processing programs to process barometric pressure, blood pressure, blood chemistry, glucose levels, electrolyte levels, skin and body temperature, core body temperature, skin hydration, and electrodermal activity data

Provision of access to global and local computer networks; provision of access to computer databases; transmission of data from computer databases via telecommunications networks and Internet

Filing History

CANCELLED SECTION 71
Jan 16, 2026 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 2, 2024 REM3
CHANGE OF OWNER RECEIVED FROM IB
Dec 11, 2020 CHLD
CHANGE OF OWNER RECEIVED FROM IB
Nov 27, 2020 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 15, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 26, 2019 FICS
FINAL DISPOSITION PROCESSED
Oct 26, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 2, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 2, 2019 R.PR
NOTIFICATION PROCESSED BY IB
May 31, 2019 GPNX
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 30, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 30, 2019 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 16, 2019 NPUB
PUBLISHED FOR OPPOSITION
Apr 16, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 27, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2019 OP2R
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 12, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 11, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 11, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 11, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 11, 2019 CNEA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Dec 7, 2018 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 21, 2018 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 21, 2018 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 14, 2018 GNFN
FINAL REFUSAL E-MAILED
Sep 14, 2018 GNFR
FINAL REFUSAL WRITTEN
Sep 14, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 28, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 28, 2018 CRFA
ASSIGNED TO LIE
Aug 27, 2018 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 7, 2018 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 25, 2018 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 25, 2018 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 25, 2018 GNSL
SUSPENSION LETTER WRITTEN
Jan 25, 2018 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 4, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 4, 2018 TROA
REFUSAL PROCESSED BY IB
Jul 28, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 6, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 5, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 28, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jun 27, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jun 23, 2017 MAFR
ASSIGNED TO EXAMINER
Jun 19, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 19, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 15, 2017 REPR